Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Fostering Innovation in Symptom Management among Hemodialysis Patients: Paths Forward for Insomnia, Muscle Cramps, and Fatigue.

Flythe JE, Hilliard T, Lumby E, Castillo G, Orazi J, Abdel-Rahman EM, Pai AB, Rivara MB, St Peter WL, Weisbord SD, Wilkie CM, Mehrotra R; Kidney Health Initiative Prioritizing Symptoms of ESRD Patients for Developing Therapeutic Interventions Stakeholder Meeting Participants.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):150-160. doi: 10.2215/CJN.07670618. Epub 2018 Nov 5.

PMID:
30397026
2.

Symptom Prioritization among Adults Receiving In-Center Hemodialysis: A Mixed Methods Study.

Flythe JE, Hilliard T, Castillo G, Ikeler K, Orazi J, Abdel-Rahman E, Pai AB, Rivara MB, St Peter WL, Weisbord SD, Wilkie C, Mehrotra R.

Clin J Am Soc Nephrol. 2018 May 7;13(5):735-745. doi: 10.2215/CJN.10850917. Epub 2018 Mar 20.

3.

Weekly Standard Kt/Vurea and Clinical Outcomes in Home and In-Center Hemodialysis.

Rivara MB, Ravel V, Streja E, Obi Y, Soohoo M, Cheung AK, Himmelfarb J, Kalantar-Zadeh K, Mehrotra R.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):445-455. doi: 10.2215/CJN.05680517. Epub 2018 Jan 11.

4.

Impact of Obesity on Modality Longevity, Residual Kidney Function, Peritonitis, and Survival Among Incident Peritoneal Dialysis Patients.

Obi Y, Streja E, Mehrotra R, Rivara MB, Rhee CM, Soohoo M, Gillen DL, Lau WL, Kovesdy CP, Kalantar-Zadeh K.

Am J Kidney Dis. 2018 Jun;71(6):802-813. doi: 10.1053/j.ajkd.2017.09.010. Epub 2017 Dec 7.

5.

Association between Testosterone and Mortality Risk among U.S. Males Receiving Dialysis.

Yu J, Ravel VA, You AS, Streja E, Rivara MB, Potukuchi PK, Brunelli SM, Kovesdy CP, Kalantar-Zadeh K, Rhee CM.

Am J Nephrol. 2017;46(3):195-203. doi: 10.1159/000480302. Epub 2017 Sep 1.

6.

Timing of Dialysis Initiation: What Has Changed Since IDEAL?

Rivara MB, Mehrotra R.

Semin Nephrol. 2017 Mar;37(2):181-193. doi: 10.1016/j.semnephrol.2016.12.008. Review.

7.

Diurnal and Long-term Variation in Plasma Concentrations and Renal Clearances of Circulating Markers of Kidney Proximal Tubular Secretion.

Rivara MB, Zelnick LR, Hoofnagle AN, Newitt R, Tracy RP, Kratz M, Weigle DS, Kestenbaum BR.

Clin Chem. 2017 Apr;63(4):915-923. doi: 10.1373/clinchem.2016.260117. Epub 2017 Feb 10.

8.

Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial.

Rivara MB, Yeung CK, Robinson-Cohen C, Phillips BR, Ruzinski J, Rock D, Linke L, Shen DD, Ikizler TA, Himmelfarb J.

Am J Kidney Dis. 2017 Mar;69(3):389-399. doi: 10.1053/j.ajkd.2016.08.041. Epub 2016 Dec 4.

9.

Development and Validation of a Novel Laboratory-Specific Correction Equation for Total Serum Calcium and Its Association With Mortality Among Hemodialysis Patients.

Obi Y, Nguyen DV, Streja E, Rivara MB, Rhee CM, Lau WL, Chen Y, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K.

J Bone Miner Res. 2017 Mar;32(3):549-559. doi: 10.1002/jbmr.3013. Epub 2016 Nov 1.

10.

Survival of Elderly Adults Undergoing Incident Home Hemodialysis and Kidney Transplantation.

Molnar MZ, Ravel V, Streja E, Kovesdy CP, Rivara MB, Mehrotra R, Kalantar-Zadeh K.

J Am Geriatr Soc. 2016 Oct;64(10):2003-2010. doi: 10.1111/jgs.14321. Epub 2016 Sep 9.

11.

Indication for Dialysis Initiation and Mortality in Patients With Chronic Kidney Failure: A Retrospective Cohort Study.

Rivara MB, Chen CH, Nair A, Cobb D, Himmelfarb J, Mehrotra R.

Am J Kidney Dis. 2017 Jan;69(1):41-50. doi: 10.1053/j.ajkd.2016.06.024.

12.

Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease.

Rivara MB, Adams SV, Kuttykrishnan S, Kalantar-Zadeh K, Arah OA, Cheung AK, Katz R, Molnar MZ, Ravel V, Soohoo M, Streja E, Himmelfarb J, Mehrotra R.

Kidney Int. 2016 Dec;90(6):1312-1320. doi: 10.1016/j.kint.2016.06.028. Epub 2016 Aug 20.

13.

A wearable artificial kidney for patients with end-stage renal disease.

Gura V, Rivara MB, Bieber S, Munshi R, Smith NC, Linke L, Kundzins J, Beizai M, Ezon C, Kessler L, Himmelfarb J.

JCI Insight. 2016 Jun 2;1(8). pii: 86397. doi: 10.1172/jci.insight.86397.

14.

Serum Magnesium Levels and Hospitalization and Mortality in Incident Peritoneal Dialysis Patients: A Cohort Study.

Yang X, Soohoo M, Streja E, Rivara MB, Obi Y, Adams SV, Kalantar-Zadeh K, Mehrotra R.

Am J Kidney Dis. 2016 Oct;68(4):619-627. doi: 10.1053/j.ajkd.2016.03.428. Epub 2016 Jun 1.

15.

New-Onset Diabetes in Peritoneal Dialysis Patients - Which Predictors Really Matter?

Rivara MB, Mehrotra R.

Perit Dial Int. 2016 May-Jun;36(3):243-6. doi: 10.3747/pdi.2015.00251. No abstract available.

16.

Hidden Hypercalcemia and Mortality Risk in Incident Hemodialysis Patients.

Obi Y, Mehrotra R, Rivara MB, Streja E, Rhee CM, Lau WL, Kovesdy CP, Kalantar-Zadeh K.

J Clin Endocrinol Metab. 2016 Jun;101(6):2440-9. doi: 10.1210/jc.2016-1369. Epub 2016 Apr 5.

17.

Association of Vascular Access Type with Mortality, Hospitalization, and Transfer to In-Center Hemodialysis in Patients Undergoing Home Hemodialysis.

Rivara MB, Soohoo M, Streja E, Molnar MZ, Rhee CM, Cheung AK, Katz R, Arah OA, Nissenson AR, Himmelfarb J, Kalantar-Zadeh K, Mehrotra R.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):298-307. doi: 10.2215/CJN.06570615. Epub 2016 Jan 4.

18.

Racial and Ethnic Disparities in Use of and Outcomes with Home Dialysis in the United States.

Mehrotra R, Soohoo M, Rivara MB, Himmelfarb J, Cheung AK, Arah OA, Nissenson AR, Ravel V, Streja E, Kuttykrishnan S, Katz R, Molnar MZ, Kalantar-Zadeh K.

J Am Soc Nephrol. 2016 Jul;27(7):2123-34. doi: 10.1681/ASN.2015050472. Epub 2015 Dec 10.

19.

Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients.

Rivara MB, Ikizler TA, Ellis CD, Mehrotra R, Himmelfarb J.

BMC Nephrol. 2015 Jun 5;16:79. doi: 10.1186/s12882-015-0074-9.

20.

Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis.

Rivara MB, Ravel V, Kalantar-Zadeh K, Streja E, Lau WL, Nissenson AR, Kestenbaum B, de Boer IH, Himmelfarb J, Mehrotra R.

J Am Soc Nephrol. 2015 Jul;26(7):1671-81. doi: 10.1681/ASN.2014050472. Epub 2015 Jan 22.

21.

Changes in symptom burden and physical performance with initiation of dialysis in patients with chronic kidney disease.

Rivara MB, Robinson-Cohen C, Kestenbaum B, Roshanravan B, Chen CH, Himmelfarb J, Mehrotra R.

Hemodial Int. 2015 Jan;19(1):147-50. doi: 10.1111/hdi.12244. Epub 2014 Nov 18. No abstract available.

22.

Self-rated health and adverse events in CKD.

Robinson-Cohen C, Hall YN, Katz R, Rivara MB, de Boer IH, Kestenbaum BR, Himmelfarb J.

Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2044-51. doi: 10.2215/CJN.03140314. Epub 2014 Oct 9.

23.

A pilot randomized crossover trial assessing the safety and short-term effects of pomegranate supplementation in hemodialysis patients.

Rivara MB, Mehrotra R, Linke L, Ruzinski J, Ikizler TA, Himmelfarb J.

J Ren Nutr. 2015 Jan;25(1):40-9. doi: 10.1053/j.jrn.2014.07.006. Epub 2014 Sep 11.

24.

The changing landscape of home dialysis in the United States.

Rivara MB, Mehrotra R.

Curr Opin Nephrol Hypertens. 2014 Nov;23(6):586-91. doi: 10.1097/MNH.0000000000000066. Review.

25.

Is early initiation of dialysis harmful?

Rivara MB, Mehrotra R.

Semin Dial. 2014 May-Jun;27(3):250-2. doi: 10.1111/sdi.12218. Epub 2014 Mar 13. No abstract available.

26.

Prognostic significance of elevated cardiac troponin-T levels in acute respiratory distress syndrome patients.

Rivara MB, Bajwa EK, Januzzi JL, Gong MN, Thompson BT, Christiani DC.

PLoS One. 2012;7(7):e40515. doi: 10.1371/journal.pone.0040515. Epub 2012 Jul 12.

27.

Dad, may I have the keys? Factors influencing which vehicles teenagers drive.

Rivara FP, Rivara MB, Bartol K.

Pediatrics. 1998 Nov;102(5):E57.

PMID:
9794987

Supplemental Content

Loading ...
Support Center